Ładuje się......
Use of inhibitors of the renin–angiotensin system is associated with longer survival in patients with hepatocellular carcinoma
BACKGROUND: Inhibition of the renin–angiotensin system (RAS) was associated with longer survival in patients with different solid malignancies. OBJECTIVE: The objective of this study was to investigate the effect of RAS inhibitor (RASi) treatment (angiotensin-converting enzyme inhibitors or angioten...
Zapisane w:
| Wydane w: | United European Gastroenterol J |
|---|---|
| Główni autorzy: | , , , , , , , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
SAGE Publications
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5676550/ https://ncbi.nlm.nih.gov/pubmed/29163965 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640617695698 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|